Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2011
10/27/2011US20110263710 Transepithelial methods of using gamma aminobutyric acid compositions for pain relief
10/27/2011US20110263704 Methods of Using Cycloalkylmethylamines
10/27/2011US20110263701 Gabapentin enacarbil compositions
10/27/2011US20110263699 1-Phenyl-2-DimethylaminomethylCyclohexane Compounds and Therapies for Depressive Symptoms, Pain and Incontinence
10/27/2011US20110263696 Proanthocyanidins from cinnamon and its water soluble extract inhibit tau aggregation
10/27/2011US20110263687 Rna molecules and uses thereof
10/27/2011US20110263678 Inhibitors of tgf-r signaling for treatment of cns disorders
10/27/2011US20110263662 1,2-diamido-ethylene derivatives as orexin antagonists
10/27/2011US20110263661 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
10/27/2011US20110263659 Analogs of 1-Methylnicotinamide
10/27/2011US20110263658 Renin inhibitors
10/27/2011US20110263656 Pirfenidone Treatment for Patients with Atypical Liver Function
10/27/2011US20110263654 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
10/27/2011US20110263651 Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011US20110263643 2,3-Disubstituted Piperidine Orexin Receptor Antagonists
10/27/2011US20110263640 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011US20110263630 Synthesis of metabolically stable agents for alcohol and drug abuse
10/27/2011US20110263629 Amides of diazabicyclooctanes and uses thereof
10/27/2011US20110263628 N-hydroxyamide derivatives and use thereof
10/27/2011US20110263626 Novel bradykinin b1-antagonists
10/27/2011US20110263615 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/27/2011US20110263613 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
10/27/2011US20110263612 Compounds that modulate intracellular calcium
10/27/2011US20110263607 Alpha helix mimetics in the treatment of cancer
10/27/2011US20110263605 Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
10/27/2011US20110263604 Oxidase inhibitors and their use
10/27/2011US20110263600 Method for preventing or treating a disease related to the glucocorticoid receptor
10/27/2011US20110263595 Compounds and methods for kinase modulation, and indications therefor
10/27/2011US20110263594 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
10/27/2011US20110263593 NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS
10/27/2011US20110263592 Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/27/2011US20110263591 2-heteroaryl carboxamides
10/27/2011US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease
10/27/2011US20110263588 Tricyclic compounds as glutamate receptor modulators
10/27/2011US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011US20110263580 Method for treating alzheimer's disease and related conditions
10/27/2011US20110263578 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011US20110263577 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
10/27/2011US20110263575 Compounds Useful as Protein Kinase Inhibitors
10/27/2011US20110263573 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011US20110263549 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
10/27/2011US20110263548 Pyridone and pyridazone analogues as gpr119 modulators
10/27/2011US20110263547 C-19 steroids for specific therapeutic uses
10/27/2011US20110263542 Methods to treat pain using an alpha-2 adrenergic agonist and an endothelin antagonist
10/27/2011US20110263541 Kinase inhibitors and their use as pharmaceutical agents
10/27/2011US20110263529 Gamma secretase modulators
10/27/2011US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011US20110263519 Regulators of the hedgehog pathway, compositions and uses related thereto
10/27/2011US20110263507 Peptide analogs that are potent and selective for human neurotensin receptor subtype 2
10/27/2011US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011US20110263492 Method to generate water soluble or nonwater soluble in nanoparticulates directly in suspension of dispersion media
10/27/2011US20110263482 Complement inhibitors
10/27/2011US20110263479 Peptides
10/27/2011US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011US20110262546 Gold nanoparticles coated with polyelectrolytes and albumin
10/27/2011US20110262539 Pharmaceutical compositions
10/27/2011US20110262537 Extended release dosage form of ropinirole
10/27/2011US20110262535 Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof
10/27/2011US20110262534 polysaccharide capsule enclosing a fatty acid oil-containing emulsion
10/27/2011US20110262532 Controlled Release Hydrocodone Formulations
10/27/2011US20110262527 Cationic lipids and methods of use
10/27/2011US20110262522 Transmucosal delivery devices with enhanced uptake
10/27/2011US20110262502 Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc)
10/27/2011US20110262496 Therapeutic formulation for reduced drug side effects
10/27/2011US20110262495 Pharmaceutical emulsion compositions comprising progestogen
10/27/2011US20110262494 Low-oil pharmaceutical emulsion compositions comprising progestogen
10/27/2011US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011US20110262460 Blood-brain barrier targeting antibodies
10/27/2011US20110262458 Alzheimer's Disease Treatment Method
10/27/2011US20110262454 Novel anti-cd38 antibodies for the treatment of cancer
10/27/2011US20110262449 Method for the treatment of gout or pseudogout
10/27/2011US20110262445 Anti-il-12/il-23 antibodies
10/27/2011US20110262442 Compositions for treating cns disorders
10/27/2011US20110262438 Biological materials related to cxcr7
10/27/2011US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs
10/27/2011US20110262419 Specifically targeted catalytic antagonists and uses thereof
10/27/2011US20110262396 Combination treatments comprising protease binding proteins for inflammatory disorders
10/27/2011US20110262393 Composition comprising mesenchymal stem cells or culture solution of mesenchymal stem cells for the prevention or treatment of neural diseases
10/27/2011US20110262388 Novel inhibitors
10/27/2011US20110262387 Methods and materials for reducing or suppressing amyloid deposition
10/27/2011US20110262386 Methods of treating inflammation
10/27/2011US20110262379 Maleamic Acid Polymer Derivatives and Their Bioconjugates
10/27/2011US20110262374 Novel compound ramalin and use thereof
10/27/2011US20110262368 C21 thioethers as glucocorticoid receptor agonists
10/27/2011US20110262365 Methods of diagnosing hypersensitivity to a female reproductive hormone and treating medical conditions associated with same
10/27/2011US20110262360 Compositions Comprising Enzyme-Cleavable Phenol-Modified Opioid Prodrugs and Inhibitors Thereof
10/27/2011US20110262359 Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
10/27/2011US20110262355 Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
10/27/2011US20110262352 Aryl piperazine and their use as alpha2c antagonists
10/27/2011CA2833908A1 Cns targeting aav vectors and methods of use thereof
10/27/2011CA2797098A1 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof
10/27/2011CA2797019A1 Modulators of 5-ht receptors and methods of use thereof
10/27/2011CA2796616A1 Methods and compositions related to dopaminergic neuronal cells
10/27/2011CA2795222A1 Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
10/27/2011CA2794724A1 Oxazole derivatives useful as modulators of faah
10/27/2011CA2794127A1 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain
10/27/2011CA2786837A1 Pyrrazolopyridine derivatives
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 1833